LIVECAST Markets Briefs Calendar Search

Research

Macro Politics Crypto Prediction Markets Disclosure Wire News Archive

LIVECAST Markets

Menu

Home LIVECAST Markets Briefs Calendar Search Macro Politics Crypto Prediction Markets Disclosure Wire News Archive

Live News EQUITY L impact Jul 28, 2026, 01:12 PM UTC

Corbus Pharmaceuticals announces FDA clearance to initiate TEMPO-1 trial

Corbus Pharmaceuticals...

SquawkNews Newsroom

Corbus Pharmaceuticals...

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

CRBP

Related stories

KO shares of Coca-Cola continue gains, last up 7.1% at record high of $90.06 KO shares of Coca-Cola continue gains, last up 7.1% at record high of $90.06 L impact | EQUITY | Jul 28, 2026, 02:39 PM UTC BOEING SAYS 787 PRODUCTION SYSTEM SLOWED FOR `SEVERAL DAYS' BOEING SAYS 787 PRODUCTION SYSTEM SLOWED FOR `SEVERAL DAYS' L impact | EQUITY | Jul 28, 2026, 02:39 PM UTC BA BOEING SLOWED 787 PRODUCTION IN APRIL TO SUPPORT SUPPLY CHAIN BA BOEING SLOWED 787 PRODUCTION IN APRIL TO SUPPORT SUPPLY CHAIN L impact | EQUITY | Jul 28, 2026, 02:39 PM UTC Boeing 'continues to make progress' on certification plans Boeing 'continues to make progress' on certification plans L impact | EQUITY | Jul 28, 2026, 02:39 PM UTC SHAK highs +2.1% SHAK highs +2.1% L impact | EQUITY | Jul 28, 2026, 02:39 PM UTC S&P 500 DOWN S&P 500 DOWN L impact | EQUITY | Jul 28, 2026, 02:39 PM UTC

SQUAWK/NEWS

Real-time financial news agency for traders. Market-relevant headlines on screen and read aloud through the LiveCast audio squawk.

Pro plan coming — join the list.

Product

LiveCast
Live Markets
Session Briefs
Calendar
Search

Research

Macro
Politics
Crypto
Prediction Markets
Disclosure Wire
News Archive

For Traders

Market Movers
US Stocks
News for Traders
How to Trade News
What Is a Squawk
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews robots / sitemap Privacy Policy SquawkNews publishes factual market information and context. It is not investment advice and does not provide trade recommendations.

We use analytics (GA4, Clarity, PostHog) to improve the product. Privacy Policy